User:Tilman Schirmer/Sandbox 201
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
[[User:Tilman_Schirmer/Sandbox_200|back]] | [[User:Tilman_Schirmer/Sandbox_200|back]] | ||
| - | ''''' | + | '''''PleD''''' |
| - | + | == Intro == | |
| - | + | ||
| - | + | ||
---- | ---- | ||
| - | + | == Domain structure == | |
| Line 15: | Line 13: | ||
---- | ---- | ||
| - | + | == Protomer == | |
<applet load='2v0n' scene='User:Tilman_Schirmer/Sandbox_201/Protomer_activeated/1' size='300' frame='true' align='right' caption='2v0n' /> | <applet load='2v0n' scene='User:Tilman_Schirmer/Sandbox_201/Protomer_activeated/1' size='300' frame='true' align='right' caption='2v0n' /> | ||
| Line 24: | Line 22: | ||
---- | ---- | ||
| - | + | == Substrate binding site == | |
<applet load='2v0n' scene='User:Tilman_Schirmer/Sandbox_201/Substrate_binding_site/2' size='300' frame='true' align='right' caption='2v0n' /> | <applet load='2v0n' scene='User:Tilman_Schirmer/Sandbox_201/Substrate_binding_site/2' size='300' frame='true' align='right' caption='2v0n' /> | ||
| Line 36: | Line 34: | ||
---- | ---- | ||
| - | + | == Allosteric product binding site == | |
<applet load='2v0n' scene='User:Tilman_Schirmer/Sandbox_201/5gp/1' size='300' frame='true' align='right' caption='Insert caption here' /> | <applet load='2v0n' scene='User:Tilman_Schirmer/Sandbox_201/5gp/1' size='300' frame='true' align='right' caption='Insert caption here' /> | ||
---- | ---- | ||
| - | + | === C-di-GMP === | |
<scene name='User:Tilman_Schirmer/Sandbox_201/5gp/1'>5GP</scene> | <scene name='User:Tilman_Schirmer/Sandbox_201/5gp/1'>5GP</scene> | ||
---- | ---- | ||
| - | + | === Primary inhibition site (Ip) === | |
<scene name='User:Tilman_Schirmer/Sandbox_201/Primary_inhibition_site/2'>Primary inhibition site</scene> | <scene name='User:Tilman_Schirmer/Sandbox_201/Primary_inhibition_site/2'>Primary inhibition site</scene> | ||
| Line 53: | Line 51: | ||
---- | ---- | ||
| - | + | === Secondary inhibition site (Is) === | |
<scene name='User:Tilman_Schirmer/Sandbox_201/Secondary_inhibition_site/1'>Secondary inhibition site</scene> | <scene name='User:Tilman_Schirmer/Sandbox_201/Secondary_inhibition_site/1'>Secondary inhibition site</scene> | ||
| Line 61: | Line 59: | ||
---- | ---- | ||
| - | + | === Primary and secondary inhibition sites === | |
<scene name='User:Tilman_Schirmer/Sandbox_201/Prim_sec_inhibition_site/1'>Primary and secondary inhibition sites</scene> | <scene name='User:Tilman_Schirmer/Sandbox_201/Prim_sec_inhibition_site/1'>Primary and secondary inhibition sites</scene> | ||
| Line 70: | Line 68: | ||
---- | ---- | ||
| - | + | == Two conformations == | |
[[Image:1w25_small.png|frame|left|non-activated (1w25)]] [[Image:2v0n_small_smaller2.png|frame|center|activated (BeF3- modified; 2v0n)]] | [[Image:1w25_small.png|frame|left|non-activated (1w25)]] [[Image:2v0n_small_smaller2.png|frame|center|activated (BeF3- modified; 2v0n)]] | ||
| Line 79: | Line 77: | ||
---- | ---- | ||
| - | + | == Non-activated conformation == | |
[[1w25]] | [[1w25]] | ||
| Line 95: | Line 93: | ||
---- | ---- | ||
| - | + | == Activated conformation == | |
[[2v0n]] | [[2v0n]] | ||
Revision as of 13:47, 19 June 2009
PleD
Contents |
Intro
Domain structure
Protomer
|
: , ,
Substrate binding site
|
Allosteric product binding site
|
C-di-GMP
Primary inhibition site (Ip)
Secondary inhibition site (Is)
Primary and secondary inhibition sites
Two conformations
non-activated (1w25)
activated (BeF3- modified; 2v0n)
|
|
Non-activated conformation
|
: , ,
Activated conformation
|
